609 related articles for article (PubMed ID: 35773731)
21. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
22. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
23. Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.
Lee KT; Gopalan V; Lam AK
Histol Histopathol; 2019 Jun; 34(6):593-609. PubMed ID: 30620381
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs and prostate cancer.
Misawa A; Takayama KI; Inoue S
Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
27. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.
Liu Y; Zhang R; Qiu F; Li K; Zhou Y; Shang D; Xu Y
Mol Biosyst; 2015 Feb; 11(2):384-93. PubMed ID: 25385343
[TBL] [Abstract][Full Text] [Related]
28. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
29. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
30. [Bioinformatic analysis of immune-related lncRNA based on TCGA database in patients with prostate cancer].
Wang Y; Wang Y; DI F; DI Z; Xi P; Wen Y; Ye Z; Ren C; Wen J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Feb; 37(2):113-118. PubMed ID: 33504416
[TBL] [Abstract][Full Text] [Related]
31. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
33. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA SAP30L-AS1 promotes prostate cancer growth through repressing SAP30L.
Qin X; Zhu W; Lu A; Wang G; Ye X; Weng G
Gene; 2019 Mar; 690():120-128. PubMed ID: 30599235
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract][Full Text] [Related]
36. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA HOXD-AS1 in cancer.
Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
[TBL] [Abstract][Full Text] [Related]
40. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]